Cellyan Biotechnology (HKPD) Non-Current Assets (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Non-Current Assets of $776298.0 for Q3 2025, down 39.47% year-over-year from $1.3 million in Q3 2024, and up 12.48% quarter-over-quarter from $690171.0 in Q1 2025.
Cellyan Biotechnology (HKPD) Non-Current Assets (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Non-Current Assets for 2 consecutive years, with $776298.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Non-Current Assets fell 39.47% year-over-year to $776298.0; the TTM figure through Sep 2025 stood at $776298.0 (down 39.47% YoY), while the FY2025 annual figure was $690171.0, down 20.26% from the prior year.
- Non-Current Assets grew to $776298.0 in Q3 2025 per HKPD's latest filing, from $690171.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.3 million in Q3 2024 and bottomed at $690171.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 25.49 Bn |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 28.47 Bn |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 18.55 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 6.78 Bn |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | 87,231.00 |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | 15.53 Mn |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | 1.84 Bn |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | 10.55 Mn |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | 24.79 Mn |
| 10 | Cellyan Biotechnology | 6.55 Mn | 6.32 Mn | - | 510,771.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 510,771.00 |
| Sep 30, 2025 | 776,298.00 |
| Mar 31, 2025 | 690,171.00 |
| Sep 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 865,518.00 |